As per the current market research conducted by the CMI Team, the global Drug Addiction Treatment Market size is expected to record a CAGR of 7.5% from 2024 to 2033. In 2023, the market size is projected to reach a valuation of USD 18.6 Billion. By 2033, the valuation is anticipated to reach USD 36.8 Billion.
Drug Addiction Treatment Market – Overview
According to industry experts at CMI, the rising prevalence of substance use disorders especially in developed regions such as the US and Europe influencing the drug addiction treatment sector. In addition, the growing number of established players operating in the market as well as the rising product approvals by governmental agencies such as the FDA also favoring the revenue growth in the target market.
Furthermore, the increasing number of campaigns and educational programs with the efforts of governmental and non-governmental bodies propelling the growth. Moreover, the increasingly innovative products and solutions for opioid treatment provide an attractive opportunity for the growth of the global drug addiction industry. However, the stringent regulation and the high cost of treatment hinder the industry expansion.
Drug Addiction Treatment Market: Growth Factors and Dynamics
Rising number of campaign and product launches
The growing number of campaigns by the agency fueled the expansion of the drug addiction industry over the analysis period. For instance, Texas Health and Human Services provided USD 23.2 million in March 2022 to support a public awareness campaign to prevent substance abuse disorders and increase access to services and treatment for addiction.
Similarly, in February 2023, Sesh+, a smoking cessation company with the motive of preventing addiction and providing treatment, developed NRT products in flavors, such as cinnamon, pomegranate, and wintergreen, to enhance the adoption of treatment.
Rising hospital applications
Hospitalization rates for serious diseases have decreased owing to the factor of increased knowledge among consumers. However, the number of rehabilitation facilities is growing, as is the use of addiction treatment herbs. The primary cause is the early diagnosis of the disease, which is predicted to raise demand for the basic treatment options offered by residential treatment facilities.
The market has seen a large influx of treatment facilities with partnerships with private recovery facilities, which has assisted in increasing the number of people in society who can get treatment, driving the market.
High cost of treatment
One of the major restraining factors hindering the market growth is its high cost of treatment. This cost can vary according to the type of treatment, duration of patient care, types of therapies and medication used. For instance, the high cost of drug addiction treatment is found in residential or inpatient treatment facilities. Where patients need round-the-clock assistance. These add a significant amount of amount of funds according to the patient’s stays. Moreover, the high cost of MAT treatment also adds an extra cost, limiting the market expansion.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 18.6 Billion |
| Projected Market Size in 2033 | USD 36.8 Billion |
| Market Size in 2023 | USD 17.9 Billion |
| CAGR Growth Rate | 7.5% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Type, Treatment, Route of Administration, End Users, Distribution Channel and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your research requirements. |
Drug Addiction Treatment Market: New Launches and Acquisitions
- In February 2023, Jovive Health introduced Medication-Assisted Treatment (MAT) to assist patients with Opioid Use Disorders (OUD) which will reduce opioid dependence.
- In January 2022, Pfizer in collaboration with the Stockholm-based Digital Therapeutics (DTx) startup Alex Therapeutics provided patients with evidence-based, clinically verified, and customized digital medicines.
List of the prominent players in the Global Drug Addiction Treatment Market:
- Medtronic
- Takeda Pharmaceutical Company Limited
- Hoffmann-La Roche Ltd
- Abbott
- BD
- Johnson & Johnson Services Inc.
- GSK Plc
- Bayer AG
- Stryker Corporation
- Zimmer Biomet
- Homology Medicines Inc
- Novartis AG
- AVROBIO Inc
- JCR Pharmaceuticals Co. Ltd.
- Sangamo Therapeutics
- Pfizer Inc.
- REGENXBIO Inc
- CANbridge Life Sciences Ltd.
- Denali Therapeutics
- Jasper Therapeutics Inc.
- Others
The Global Drug Addiction Treatment Market is segmented as follows:
By Type
- Opioid Addiction
- Benzodiazepine Addiction
- Barbiturate Addiction
- Others
By Treatment
- Therapy
- Medication
- Others
By Route of Administration
- Oral
- Parenteral
- Others
By End Users
- Hospitals
- Specialty Clinics
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacies
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America